Nath Bio-Genes (India) Ltd

Nath Bio-Genes Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Nath Bio-Genes (India) Ltd

₹ 206 0.93%
12 Jun - close price
nathbiogenes.com BSE: 537291 NSE: NATHBIOGEN
About

Incorporated in 1993, Nath Bio-Genes Ltd
is in the business of Production, Processing,
and Marketing of Hybrid and GM Seeds[1]

Key Points

Business Overview:[1][2][3]
NBGL is a flagship company of Nath Group.
It is an agri-tech company in the business of developing and supplying quality BT, hybrid, and varietal seeds to farmers at affordable prices. It does the production and processing of commercial and vegetable seeds on lands taken on lease from various growers /farmers throughout India. The company enters into seed production agreements with these farmers/growers and compensates them for various cultivation expenses based on the rate agreement entered into

Website BSE NSE
  • Market Cap ₹ 391 Cr.
  • Current Price ₹ 206
  • High / Low ₹ 264 / 138
  • Stock P/E 10.3
  • Book Value ₹ 339
  • Dividend Yield 0.97 %
  • ROCE 6.79 %
  • ROE 6.07 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Stock is trading at 0.61 times its book value
  • Debtor days have improved from 127 to 88.9 days.

Cons

  • Tax rate seems low
  • Company has a low return on equity of 6.16% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Fast Moving Consumer Goods Fast Moving Consumer Goods Agricultural Food & other Products Other Agricultural Products

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
27.21 209.35 21.73 25.30 44.99 235.28 22.57 31.74 43.04 243.88 32.19 36.87 51.97
48.52 174.91 16.98 19.68 41.06 198.26 17.58 26.09 39.11 207.34 27.38 28.83 51.55
Operating Profit -21.31 34.44 4.75 5.62 3.93 37.02 4.99 5.65 3.93 36.54 4.81 8.04 0.42
OPM % -78.32% 16.45% 21.86% 22.21% 8.74% 15.73% 22.11% 17.80% 9.13% 14.98% 14.94% 21.81% 0.81%
-88.05 0.04 0.20 0.06 0.26 0.12 0.06 2.54 1.36 0.13 0.08 0.48 4.40
Interest 2.47 2.88 2.75 2.96 1.53 2.76 2.44 2.84 1.07 2.24 2.98 3.90 1.37
Depreciation 1.05 0.67 0.67 0.67 0.99 0.76 0.76 0.76 0.98 0.83 0.83 0.83 1.34
Profit before tax -112.88 30.93 1.53 2.05 1.67 33.62 1.85 4.59 3.24 33.60 1.08 3.79 2.11
Tax % 3.07% 0.55% 3.92% 34.15% 13.77% 0.65% 18.92% 16.78% 19.14% 0.74% -2.78% 30.08% 29.86%
-116.33 30.76 1.47 1.35 1.43 33.41 1.50 3.82 2.62 33.35 1.11 2.65 1.48
EPS in Rs -61.21 16.19 0.77 0.71 0.76 17.59 0.79 2.02 1.38 17.55 0.58 1.39 0.78
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012 Mar 2013 Mar 2022 Mar 2023 Mar 2024 Mar 2025
97 109 230 234 248 365
82 89 193 185 198 315
Operating Profit 15 20 37 49 50 50
OPM % 15% 18% 16% 21% 20% 14%
1 1 -87 1 4 5
Interest 2 4 11 10 9 10
Depreciation 5 5 3 3 3 4
Profit before tax 9 12 -63 36 42 41
Tax % -1% 4% 6% 3% 5% 5%
9 12 -67 35 40 39
EPS in Rs 5.75 7.34 -35.46 18.43 20.85 20.31
Dividend Payout % 0% 0% -6% 11% 10% 10%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 17%
TTM: 47%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 17%
TTM: 5%
Stock Price CAGR
10 Years: 8%
5 Years: -9%
3 Years: 4%
1 Year: 2%
Return on Equity
10 Years: %
5 Years: %
3 Years: 6%
Last Year: 6%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012 Mar 2013 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 16 16 19 19 19 19
Reserves 30 41 523 554 591 625
11 19 93 105 110 122
63 82 105 114 160 259
Total Liabilities 120 158 739 793 880 1,026
21 38 245 244 249 250
CWIP 0 0 0 0 0 0
Investments 1 0 5 5 6 6
99 121 490 543 625 770
Total Assets 120 158 739 793 880 1,026

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012 Mar 2013 Mar 2022 Mar 2023 Mar 2024 Mar 2025
17 38 75 18
-20 -3 -27 -4
-22 -2 -8 -2
Net Cash Flow -25 34 39 11

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012 Mar 2013 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 47 70 136 152 139 89
Inventory Days 587 667 4,388
Days Payable 146 239 586
Cash Conversion Cycle 487 499 136 3,954 139 89
Working Capital Days 109 122 573 579 497 345
ROCE % 24% 7% 7% 7%

Shareholding Pattern

Numbers in percentages

1 Recently
Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
41.07% 45.59% 45.59% 45.59% 45.59% 45.59% 45.59% 45.59% 45.59% 45.59% 45.59% 45.59%
0.11% 0.01% 0.15% 0.13% 0.07% 0.22% 0.32% 0.27% 0.21% 0.18% 0.19% 0.21%
4.62% 4.62% 4.62% 4.62% 4.62% 4.37% 4.37% 4.37% 4.37% 4.37% 4.37% 3.94%
54.20% 49.77% 49.62% 49.65% 49.71% 49.81% 49.72% 49.76% 49.80% 49.83% 49.83% 50.24%
No. of Shareholders 35,48435,47034,74933,96033,50234,36534,26335,13235,83435,42335,05634,911

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls